NKTX · NASDAQ · Biotechnology

Nkarta (NKTX)

Develops NKX019-led CAR NK therapies for B-cell autoimmune diseases.

$2.95
After hours+0.01 (+0.17%)
At close$2.95(+2.26%)

Something off on this page? Send us feedback.

Next report
Nov 10, 26
estimated · in 49 days
EPS estimate
−$0.40
Revenue estimate
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.35−$0.43−$0.31−$0.29−$0.37−$0.37−$0.54Pending
Estimate−$0.41−$0.44−$0.37−$0.32−$0.32−$0.39−$0.36−$0.40
Surprise+14.6%+2.3%+16.2%+9.4%−15.6%+5.1%−49.9%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
ReportedPending
Estimate
Surprise

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2027−$0.41
Sep 2027−$0.40
Jun 2027−$0.41
Mar 2027−$0.42
Dec 2026−$0.39
Nov 2026−$0.40
Aug 2026−$0.36−$0.54−49.9%
May 2026−$0.39−$0.37+5.1%
Mar 2026−$0.32−$0.37−15.6%
Nov 2025−$0.32−$0.29+9.4%
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
Jul 2020
Dec 2019
Sep 2019
Jun 2019
Mar 2019

The latest year is open to everyone — the 26 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2027−$0.41$0
Sep 2027−$0.40$0
Jun 2027−$0.41$0
Mar 2027−$0.42$0
Dec 2026−$0.39$0
Nov 10, 2026−$0.40$0
Aug 10, 2026−$0.36−$0.54−49.9%−5.3%
May 12, 2026−$0.39−$0.37+5.1%+3.1%
Mar 25, 2026−$0.32−$0.37−15.6%+3.9%
Nov 10, 2025−$0.32−$0.29+9.4%0.0%
Aug 12, 2025
May 14, 2025
Mar 26, 2025
Nov 7, 2024
Aug 13, 2024
May 9, 2024
Mar 21, 2024
Nov 9, 2023
Aug 10, 2023
May 11, 2023
Mar 16, 2023
Nov 9, 2022
Aug 11, 2022
May 12, 2022
Mar 17, 2022
Nov 10, 2021
Aug 12, 2021
May 13, 2021
Mar 25, 2021
Nov 12, 2020
Aug 20, 2020
Jul 13, 2020
Dec 31, 2019
Sep 30, 2019
Jun 30, 2019
Mar 31, 2019

The latest year is open to everyone — the 26 quarters behind it read with an account.